Mitesco, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
MITIStored price and day change unavailable
Contents
Item 1. Consolidated Balance Sheets as of September 30, 2025, and December 31, 2024
CONSOLIDATED BALANCE SHEETS
| September 30 | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (Unaudited) | ||
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $321 | $3,402 |
| Accounts receivable | 36,300 | 29,700 |
| Prepaid expenses and other current assets | 3,651 | 4,968 |
| Total current assets | 40,272 | 38,070 |
| Intangible assets, net | 125,420 | 151,771 |
| Total Assets | $165,692 | $189,841 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $4,301,610 | $4,167,061 |
| Accrued interest | 384,605 | 374,376 |
| Accrued interest - related parties | - | 22,547 |
| Derivative liabilities | 1,172,020 | 4,685,675 |
| Royalty payable | 150,000 | 150,000 |
| Deferred revenue | 10,000 | - |
| Lease liability - operating leases, current | 99,477 | 99,477 |
| Notes payable | 641,666 | 548,137 |
| Notes payable - related parties | - | 64,044 |
| SBA loan payable | 374,643 | 393,761 |
| Other current liabilities | 96,136 | 96,136 |
| Preferred stock dividends payable - related parties | - | 14,439 |
| Legal settlements | 3,322,834 | 2,666,675 |
| Series A preferred stock liability, current | 7,030,279 | 5,160,815 |
| Total current liabilities | 17,583,270 | 18,443,143 |
| Series A preferred stock liability, non-current | 6,367,442 | 8,162,644 |
| Total liabilities | 23,950,712 | 26,605,787 |
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity (deficit) | ||
| Preferred stock, $0.01 par value, 100,000,000 shares authorized; 10,000,000 shares designated Series D; 10,000 shares designated as Series E; 140,000 shares designated as Series F; and 31,427 shares designated Series X: | ||
| Preferred stock, Series D, $0.01 par value, no shares and 25,000 shares issued and outstanding as of September 30, 2025, and December 31, 2024 respectively | - | 250 |
| Preferred stock, Series F, $0.01 par value, no shares issued and outstanding as of September 30, 2025, and December 31, 2024 respectively | - | - |
| Preferred stock, Series X, $0.01 par value, 42,103 and 19,703 shares issued and outstanding at September 30, 2025, and December 31, 2024 respectively | 421 | 197 |
| Common stock, $0.01 par value, 500,000,000 shares authorized, 15,093,055 and 9,762,258 shares issued and outstanding as of September 30, 2025, and December 31, 2024, respectively | 150,931 | 97,623 |
| Additional paid-in capital | 39,758,998 | 37,341,335 |
| Accumulated deficit | (63,695,370) | (63,855,351) |
| Total stockholders’ equity (deficit) | (23,785,020) | (26,415,946) |
| Total liabilities and stockholders’ equity (deficit) | $165,692 | $189,841 |
See accompanying notes to these unaudited consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.